Kurzfassung

A Phase 3, multicenter, rendomized, double-blind, placebo-controlled, parallel-group study of the efficacy and saffety of 2 oral doses of CP-690,550 and 1 1 subcoutanous dose of etanercept in subjects with moderate to severe chronique plaque psoriasis